-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Shanghai Henlius Biotech Says Phase 1 Clinical Trial Of Nivolumab Biosimilar HLX18 Approved By FDA

Reuters·12/19/2025 09:53:10

Please log in to view news